3151. PCR. Borrelia burgdorferi sensu (CSF, qualitative determination)
Turnaround time (days): 3
1250 ₴
Description
Lyme borreliosis (Lyme disease) is a bacterial infectious disease transmitted to humans through the bites of Ixodes ticks. This test allows the detection of genetic material of Borrelia burgdorferi sensu lato in the blood or cerebrospinal fluid (CSF) of patients with tick-borne borreliosis, which is absent in healthy individuals. It is a specific and rapid method for diagnosing tick-borne borreliosis. PCR enables diagnosis at an early stage and the initiation of appropriate treatment, helping to prevent the development of complications. In addition, PCR allows for monitoring treatment effectiveness – a positive result indicates the presence of the pathogen and the need to continue or adjust therapy. Sampling of material, specifically blood or CSF, helps determine the role of Borrelia in a particular clinical condition (e.g., neuroborreliosis).
When and who needs the test?
- Diagnosis of tick-borne borreliosis in seronegative patients (immunological defects: congenital and acquired, coinfections, asymptomatic course or latent stage of the disease – activation of the infection may manifest months or even years after contact with the vector);
- Confirmation of borreliosis infection of the nervous system;
- Meningopolyradiculoneuritis (Bannwarth syndrome);
- Encephalomyelitis;
- Differential diagnosis of autoimmune and infectious joint involvement following tick-borne borreliosis;
- In cases of suspected reinfection with B. burgdorferi sl;
- Evaluation of the effectiveness of treatment for tick-borne borreliosis.
Biological material
- Cerebrospinal fluid (CSF)
Preparation as recommended by your doctor
The sampling should be done by your doctor. Deliver collected biomaterial to the laboratory for testing.